Nuformix touts patent wins for idiopathic pulmonary fibrosis treatment (2024)

`,data() {return {tabs: [] };},created() {this.tabs = this.$children;},methods: {selectTab(selectedTab) {this.tabs.forEach(tab => {tab.isActive = (tab.name == selectedTab.name);});}}});Vue.component('tab', {template: `

`,props: {name: { required: true },selected: { default: false}},data() {return {isActive: false};},computed: {href() {return '#' + this.name.toLowerCase().replace(/ /g, '-');}},mounted() {this.isActive = this.selected;}});Vue.component('newslist', {template: `

`,props: {source: { required: true },rawarticles: { required: true },limit: { default: 12 }},methods: {processData: function(articles){if(articles.length > this.limit){articles = articles.slice(0, this.limit);}this.articles = articles;this.loaded = true;Vue.nextTick(function(){});},stripRedudancies: function(articles){return _.uniqBy(articles, "headline");}},data() {return {loaded: false,articles: []};},mounted() {this.processData(this.rawarticles);}});new Vue({el: '#nw-news-widget',data: {loaded: false,availableTabs: {"Press Releases": [{"headline":"IN BRIEF: Nuformix shares fall despite interim loss narrowing","short_text":"ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Posts no revenue in the six months ...","one_line_short_text":"ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Posts no revenue in the six months ...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/94064623\/in-brief-nuformix-shares-fall-despite-interim-los","source":"Alliance News","source_logo":"\/common\/images\/news-sources\/alnc.png","tags":[],"timestamp":1718732225,"date":"Tue Jun 18, 2024 ","time":"1:37 PM (4 days ago)","full_date":"June 18, 2024 1:37 PM","post_time":"June 18 2024","article_id":94064623,"source_id":"alnc","media_url":null,"press_release":true},{"headline":"Nuformix PLC Half-year Report","short_text":" Nuformix PLC 18 June 2024 \u00a0 Nuformix plc \u00a0 (\"Nuformix\", the \"Company\" or the \"Group\") \u00a0 Half Year Report \u00a0 18 June 2024: Nuformix plc (LSE: NFX), a pharmaceutical development company targeting...","one_line_short_text":"Nuformix PLC 18 June 2024 \u00a0 Nuformix plc \u00a0 (\"Nuformix\", the \"Company\" or the \"Group\") \u00a0 Half Year Report \u00a0 18 June 2024: Nuformix plc (LSE:...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/94058796\/nuformix-plc-half-year-report","source":"RNS Regulatory News","source_logo":"\/common\/images\/news-sources\/lseg_rns.png","tags":["REGULATORY"],"timestamp":1718690407,"date":"Tue Jun 18, 2024 ","time":"2:00 AM (4 days ago)","full_date":"June 18, 2024 2:00 AM","post_time":"June 18 2024","article_id":94058796,"source_id":"lseg_rns","media_url":null,"press_release":true},{"headline":"Nuformix touts patent wins for idiopathic pulmonary fibrosis treatment","short_text":" Nuformix PLC on Monday celebrated multiple patent wins, after grants in both Europe and the US signalled further prot ...","one_line_short_text":" Nuformix PLC on Monday celebrated multiple patent wins, after grants in both Europe and the US signalled further prot ...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/94051199\/nuformix-touts-patent-wins-for-idiopathic-pulmonar","source":"Alliance News","source_logo":"\/common\/images\/news-sources\/alnc.png","tags":[],"timestamp":1718617064,"date":"Mon Jun 17, 2024 ","time":"5:37 AM (5 days ago)","full_date":"June 17, 2024 5:37 AM","post_time":"June 17 2024","article_id":94051199,"source_id":"alnc","media_url":null,"press_release":true},{"headline":"Nuformix PLC Patent Update","short_text":" Nuformix PLC 17 June 2024 \u00a0 17 June 2024 \u00a0 \u00a0 Nuformix plc \u00a0 (\"Nuformix\" or the \"Company\") \u00a0 Patent Update \u200b Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet...","one_line_short_text":"Nuformix PLC 17 June 2024 \u00a0 17 June 2024 \u00a0 \u00a0 Nuformix plc \u00a0 (\"Nuformix\" or the \"Company\") \u00a0 Patent Update \u200b Nuformix plc (LSE: NFX), a...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/94049486\/nuformix-plc-patent-update","source":"RNS Regulatory News","source_logo":"\/common\/images\/news-sources\/lseg_rns.png","tags":["REGULATORY"],"timestamp":1718604008,"date":"Mon Jun 17, 2024 ","time":"2:00 AM (5 days ago)","full_date":"June 17, 2024 2:00 AM","post_time":"June 17 2024","article_id":94049486,"source_id":"lseg_rns","media_url":null,"press_release":true},{"headline":"Nuformix PLC Result of AGM","short_text":" Nuformix PLC 19 March 2024 \u00a0 Nuformix plc (\"Nuformix\" or the \"Company\") Result of Annual General Meeting Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical...","one_line_short_text":"Nuformix PLC 19 March 2024 \u00a0 Nuformix plc (\"Nuformix\" or the \"Company\") Result of Annual General Meeting Nuformix plc (LSE: NFX), a...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/93515259\/nuformix-plc-result-of-agm","source":"RNS Regulatory News","source_logo":"\/common\/images\/news-sources\/lseg_rns.png","tags":["REGULATORY"],"timestamp":1710859142,"date":"Tue Mar 19, 2024 ","time":"10:39 AM (3 months ago)","full_date":"March 19, 2024 10:39 AM","post_time":"March 19 2024","article_id":93515259,"source_id":"lseg_rns","media_url":null,"press_release":true},{"headline":"IN BRIEF: Nuformix announces subscription to raise GBP150,000","short_text":"ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Announce intention to raise gross ...","one_line_short_text":"ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Announce intention to raise gross ...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/93399524\/in-brief-nuformix-announces-subscription-to-raise","source":"Alliance News","source_logo":"\/common\/images\/news-sources\/alnc.png","tags":[],"timestamp":1709289061,"date":"Fri Mar 01, 2024 ","time":"5:31 AM (4 months ago)","full_date":"March 1, 2024 5:31 AM","post_time":"March 01 2024","article_id":93399524,"source_id":"alnc","media_url":null,"press_release":true},{"headline":"Nuformix PLC Subscription to raise \u00a3150,000","short_text":" Nuformix PLC 01 March 2024 \u00a0 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATIONS (EU) NO. 596\/2014 WHICH FORMS PART OF DOMESTIC UK LAW...","one_line_short_text":"Nuformix PLC 01 March 2024 \u00a0 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATIONS (EU...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/93396233\/nuformix-plc-subscription-to-raise-150-000","source":"RNS Regulatory News","source_logo":"\/common\/images\/news-sources\/lseg_rns.png","tags":["REGULATORY"],"timestamp":1709276404,"date":"Fri Mar 01, 2024 ","time":"2:00 AM (4 months ago)","full_date":"March 1, 2024 2:00 AM","post_time":"March 01 2024","article_id":93396233,"source_id":"lseg_rns","media_url":null,"press_release":true},{"headline":"Nuformix PLC Posting of Annual Report and Notice of AGM","short_text":" Nuformix PLC 15 January 2024 15 January 2024 Nuformix plc ("Nuformix", the "Company" or the "Group") Posting of Annual Report and Notice of Annual General Meeting...","one_line_short_text":"Nuformix PLC 15 January 2024 15 January 2024 Nuformix plc ("Nuformix", the "Company" or the "Group") Posting of...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/93040238\/nuformix-plc-posting-of-annual-report-and-notice-o","source":"UK Regulatory","source_logo":"\/common\/images\/news-sources\/ukreg.png","tags":["REGULATORY"],"timestamp":1705318200,"date":"Mon Jan 15, 2024 ","time":"6:30 AM (5 months ago)","full_date":"January 15, 2024 6:30 AM","post_time":"January 15 2024","article_id":93040238,"source_id":"ukreg","media_url":null,"press_release":true},{"headline":"IN BRIEF: Nuformix narrows annual loss as develops drug assets","short_text":"ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 ...","one_line_short_text":"ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 ...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/92933628\/in-brief-nuformix-narrows-annual-loss-as-develops","source":"Alliance News","source_logo":"\/common\/images\/news-sources\/alnc.png","tags":[],"timestamp":1704276967,"date":"Wed Jan 03, 2024 ","time":"5:16 AM (6 months ago)","full_date":"January 3, 2024 5:16 AM","post_time":"January 03 2024","article_id":92933628,"source_id":"alnc","media_url":null,"press_release":true},{"headline":"Nuformix PLC Results for the period ended 30 September 2023","short_text":" Nuformix PLC 03 January 2024 3 January 2024 Nuformix plc ("Nuformix", the "Company" or the "Group") Annual Results for the period ended 30 September 2023 Nuformix...","one_line_short_text":"Nuformix PLC 03 January 2024 3 January 2024 Nuformix plc ("Nuformix", the "Company" or the "Group") Annual Results...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/92929487\/nuformix-plc-results-for-the-period-ended-30-septe","source":"UK Regulatory","source_logo":"\/common\/images\/news-sources\/ukreg.png","tags":["REGULATORY"],"timestamp":1704265200,"date":"Wed Jan 03, 2024 ","time":"2:00 AM (6 months ago)","full_date":"January 3, 2024 2:00 AM","post_time":"January 03 2024","article_id":92929487,"source_id":"ukreg","media_url":null,"press_release":true},{"headline":"Nuformix PLC NXP001 Update","short_text":" Nuformix PLC 18 December 2023 18 December 2023 Nuformix plc ("Nuformix" or the "Company") NXP001 Update Nuformix receives second NXP001 milestone payment from Oxilio Nuformix...","one_line_short_text":"Nuformix PLC 18 December 2023 18 December 2023 Nuformix plc ("Nuformix" or the "Company") NXP001 Update Nuformix receives...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/92829437\/nuformix-plc-nxp001-update","source":"UK Regulatory","source_logo":"\/common\/images\/news-sources\/ukreg.png","tags":["REGULATORY"],"timestamp":1702882800,"date":"Mon Dec 18, 2023 ","time":"2:00 AM (6 months ago)","full_date":"December 18, 2023 2:00 AM","post_time":"December 18 2023","article_id":92829437,"source_id":"ukreg","media_url":null,"press_release":true},{"headline":"Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002","short_text":" Nuformix PLC on Monday said it has been issued with a patent in Japan for NXP002, its potential novel inhaled treatme ...","one_line_short_text":" Nuformix PLC on Monday said it has been issued with a patent in Japan for NXP002, its potential novel inhaled treatme ...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/92338564\/nuformix-gets-patent-in-japan-for-pulmonary-fibros","source":"Alliance News","source_logo":"\/common\/images\/news-sources\/alnc.png","tags":[],"timestamp":1698061119,"date":"Mon Oct 23, 2023 ","time":"7:38 AM (8 months ago)","full_date":"October 23, 2023 7:38 AM","post_time":"October 23 2023","article_id":92338564,"source_id":"alnc","media_url":null,"press_release":true}],"All News": [{"headline":"IN BRIEF: Nuformix shares fall despite interim loss narrowing","short_text":"ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Posts no revenue in the six months ...","one_line_short_text":"ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Posts no revenue in the six months ...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/94064623\/in-brief-nuformix-shares-fall-despite-interim-los","source":"Alliance News","source_logo":"\/common\/images\/news-sources\/alnc.png","tags":[],"timestamp":1718732225,"date":"Tue Jun 18, 2024 ","time":"1:37 PM (4 days ago)","full_date":"June 18, 2024 1:37 PM","post_time":"June 18 2024","article_id":94064623,"source_id":"alnc","media_url":null,"press_release":true},{"headline":"Nuformix PLC Half-year Report","short_text":" Nuformix PLC 18 June 2024 \u00a0 Nuformix plc \u00a0 (\"Nuformix\", the \"Company\" or the \"Group\") \u00a0 Half Year Report \u00a0 18 June 2024: Nuformix plc (LSE: NFX), a pharmaceutical development company targeting...","one_line_short_text":"Nuformix PLC 18 June 2024 \u00a0 Nuformix plc \u00a0 (\"Nuformix\", the \"Company\" or the \"Group\") \u00a0 Half Year Report \u00a0 18 June 2024: Nuformix plc (LSE:...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/94058796\/nuformix-plc-half-year-report","source":"RNS Regulatory News","source_logo":"\/common\/images\/news-sources\/lseg_rns.png","tags":["REGULATORY"],"timestamp":1718690407,"date":"Tue Jun 18, 2024 ","time":"2:00 AM (4 days ago)","full_date":"June 18, 2024 2:00 AM","post_time":"June 18 2024","article_id":94058796,"source_id":"lseg_rns","media_url":null,"press_release":true},{"headline":"Nuformix touts patent wins for idiopathic pulmonary fibrosis treatment","short_text":" Nuformix PLC on Monday celebrated multiple patent wins, after grants in both Europe and the US signalled further prot ...","one_line_short_text":" Nuformix PLC on Monday celebrated multiple patent wins, after grants in both Europe and the US signalled further prot ...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/94051199\/nuformix-touts-patent-wins-for-idiopathic-pulmonar","source":"Alliance News","source_logo":"\/common\/images\/news-sources\/alnc.png","tags":[],"timestamp":1718617064,"date":"Mon Jun 17, 2024 ","time":"5:37 AM (5 days ago)","full_date":"June 17, 2024 5:37 AM","post_time":"June 17 2024","article_id":94051199,"source_id":"alnc","media_url":null,"press_release":true},{"headline":"Nuformix PLC Patent Update","short_text":" Nuformix PLC 17 June 2024 \u00a0 17 June 2024 \u00a0 \u00a0 Nuformix plc \u00a0 (\"Nuformix\" or the \"Company\") \u00a0 Patent Update \u200b Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet...","one_line_short_text":"Nuformix PLC 17 June 2024 \u00a0 17 June 2024 \u00a0 \u00a0 Nuformix plc \u00a0 (\"Nuformix\" or the \"Company\") \u00a0 Patent Update \u200b Nuformix plc (LSE: NFX), a...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/94049486\/nuformix-plc-patent-update","source":"RNS Regulatory News","source_logo":"\/common\/images\/news-sources\/lseg_rns.png","tags":["REGULATORY"],"timestamp":1718604008,"date":"Mon Jun 17, 2024 ","time":"2:00 AM (5 days ago)","full_date":"June 17, 2024 2:00 AM","post_time":"June 17 2024","article_id":94049486,"source_id":"lseg_rns","media_url":null,"press_release":true},{"headline":"Nuformix PLC Result of AGM","short_text":" Nuformix PLC 19 March 2024 \u00a0 Nuformix plc (\"Nuformix\" or the \"Company\") Result of Annual General Meeting Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical...","one_line_short_text":"Nuformix PLC 19 March 2024 \u00a0 Nuformix plc (\"Nuformix\" or the \"Company\") Result of Annual General Meeting Nuformix plc (LSE: NFX), a...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/93515259\/nuformix-plc-result-of-agm","source":"RNS Regulatory News","source_logo":"\/common\/images\/news-sources\/lseg_rns.png","tags":["REGULATORY"],"timestamp":1710859142,"date":"Tue Mar 19, 2024 ","time":"10:39 AM (3 months ago)","full_date":"March 19, 2024 10:39 AM","post_time":"March 19 2024","article_id":93515259,"source_id":"lseg_rns","media_url":null,"press_release":true},{"headline":"IN BRIEF: Nuformix announces subscription to raise GBP150,000","short_text":"ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Announce intention to raise gross ...","one_line_short_text":"ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Announce intention to raise gross ...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/93399524\/in-brief-nuformix-announces-subscription-to-raise","source":"Alliance News","source_logo":"\/common\/images\/news-sources\/alnc.png","tags":[],"timestamp":1709289061,"date":"Fri Mar 01, 2024 ","time":"5:31 AM (4 months ago)","full_date":"March 1, 2024 5:31 AM","post_time":"March 01 2024","article_id":93399524,"source_id":"alnc","media_url":null,"press_release":true},{"headline":"Nuformix PLC Subscription to raise \u00a3150,000","short_text":" Nuformix PLC 01 March 2024 \u00a0 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATIONS (EU) NO. 596\/2014 WHICH FORMS PART OF DOMESTIC UK LAW...","one_line_short_text":"Nuformix PLC 01 March 2024 \u00a0 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATIONS (EU...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/93396233\/nuformix-plc-subscription-to-raise-150-000","source":"RNS Regulatory News","source_logo":"\/common\/images\/news-sources\/lseg_rns.png","tags":["REGULATORY"],"timestamp":1709276404,"date":"Fri Mar 01, 2024 ","time":"2:00 AM (4 months ago)","full_date":"March 1, 2024 2:00 AM","post_time":"March 01 2024","article_id":93396233,"source_id":"lseg_rns","media_url":null,"press_release":true},{"headline":"Nuformix PLC Posting of Annual Report and Notice of AGM","short_text":" Nuformix PLC 15 January 2024 15 January 2024 Nuformix plc ("Nuformix", the "Company" or the "Group") Posting of Annual Report and Notice of Annual General Meeting...","one_line_short_text":"Nuformix PLC 15 January 2024 15 January 2024 Nuformix plc ("Nuformix", the "Company" or the "Group") Posting of...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/93040238\/nuformix-plc-posting-of-annual-report-and-notice-o","source":"UK Regulatory","source_logo":"\/common\/images\/news-sources\/ukreg.png","tags":["REGULATORY"],"timestamp":1705318200,"date":"Mon Jan 15, 2024 ","time":"6:30 AM (5 months ago)","full_date":"January 15, 2024 6:30 AM","post_time":"January 15 2024","article_id":93040238,"source_id":"ukreg","media_url":null,"press_release":true},{"headline":"IN BRIEF: Nuformix narrows annual loss as develops drug assets","short_text":"ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 ...","one_line_short_text":"ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 ...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/92933628\/in-brief-nuformix-narrows-annual-loss-as-develops","source":"Alliance News","source_logo":"\/common\/images\/news-sources\/alnc.png","tags":[],"timestamp":1704276967,"date":"Wed Jan 03, 2024 ","time":"5:16 AM (6 months ago)","full_date":"January 3, 2024 5:16 AM","post_time":"January 03 2024","article_id":92933628,"source_id":"alnc","media_url":null,"press_release":true},{"headline":"Nuformix PLC Results for the period ended 30 September 2023","short_text":" Nuformix PLC 03 January 2024 3 January 2024 Nuformix plc ("Nuformix", the "Company" or the "Group") Annual Results for the period ended 30 September 2023 Nuformix...","one_line_short_text":"Nuformix PLC 03 January 2024 3 January 2024 Nuformix plc ("Nuformix", the "Company" or the "Group") Annual Results...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/92929487\/nuformix-plc-results-for-the-period-ended-30-septe","source":"UK Regulatory","source_logo":"\/common\/images\/news-sources\/ukreg.png","tags":["REGULATORY"],"timestamp":1704265200,"date":"Wed Jan 03, 2024 ","time":"2:00 AM (6 months ago)","full_date":"January 3, 2024 2:00 AM","post_time":"January 03 2024","article_id":92929487,"source_id":"ukreg","media_url":null,"press_release":true},{"headline":"Nuformix PLC NXP001 Update","short_text":" Nuformix PLC 18 December 2023 18 December 2023 Nuformix plc ("Nuformix" or the "Company") NXP001 Update Nuformix receives second NXP001 milestone payment from Oxilio Nuformix...","one_line_short_text":"Nuformix PLC 18 December 2023 18 December 2023 Nuformix plc ("Nuformix" or the "Company") NXP001 Update Nuformix receives...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/92829437\/nuformix-plc-nxp001-update","source":"UK Regulatory","source_logo":"\/common\/images\/news-sources\/ukreg.png","tags":["REGULATORY"],"timestamp":1702882800,"date":"Mon Dec 18, 2023 ","time":"2:00 AM (6 months ago)","full_date":"December 18, 2023 2:00 AM","post_time":"December 18 2023","article_id":92829437,"source_id":"ukreg","media_url":null,"press_release":true},{"headline":"Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002","short_text":" Nuformix PLC on Monday said it has been issued with a patent in Japan for NXP002, its potential novel inhaled treatme ...","one_line_short_text":" Nuformix PLC on Monday said it has been issued with a patent in Japan for NXP002, its potential novel inhaled treatme ...","link":"https:\/\/ih.advfn.com\/stock-market\/london\/NFX\/stock-news\/92338564\/nuformix-gets-patent-in-japan-for-pulmonary-fibros","source":"Alliance News","source_logo":"\/common\/images\/news-sources\/alnc.png","tags":[],"timestamp":1698061119,"date":"Mon Oct 23, 2023 ","time":"7:38 AM (8 months ago)","full_date":"October 23, 2023 7:38 AM","post_time":"October 23 2023","article_id":92338564,"source_id":"alnc","media_url":null,"press_release":true}],"Preferred Contributors": ""}},created: function () {this.loaded = true;Vue.nextTick(function(){});}});});

More News Articles